AI fast-tracks novel lung disease drug

Development paves way for finding innovative treatments faster, cheaper.

An experimental drug empowered by artificial intelligence to identify a novel therapeutic target for a severe lung disease has demonstrated promising safety and efficacy results in its phase two clinical trial, according to a research paper released this week.